Dimitri Krainc

24.6k total citations · 10 hit papers
135 papers, 15.5k citations indexed

About

Dimitri Krainc is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Dimitri Krainc has authored 135 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Neurology, 61 papers in Molecular Biology and 51 papers in Physiology. Recurrent topics in Dimitri Krainc's work include Parkinson's Disease Mechanisms and Treatments (62 papers), Lysosomal Storage Disorders Research (43 papers) and Cellular transport and secretion (40 papers). Dimitri Krainc is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (62 papers), Lysosomal Storage Disorders Research (43 papers) and Cellular transport and secretion (40 papers). Dimitri Krainc collaborates with scholars based in United States, Germany and Canada. Dimitri Krainc's co-authors include Yvette C. Wong, Stuart A. Lipton, Joseph R. Mazzulli, Pierluigi Nicotera, Emanuela Bonfoco, Maria Ankarcrona, Daniel Ysselstein, Hyunkyung Jeong, Libin Cui and Naoko Tanese and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Dimitri Krainc

134 papers receiving 15.3k citations

Hit Papers

Apoptosis and necrosis: two distinct events induced, resp... 1995 2026 2005 2015 1995 2011 2006 2017 2018 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dimitri Krainc United States 57 8.3k 5.0k 4.8k 4.5k 2.4k 135 15.5k
Jie Shen United States 50 6.5k 0.8× 6.8k 1.3× 5.0k 1.0× 4.8k 1.1× 1.9k 0.8× 112 14.7k
Tiago F. Outeiro Germany 71 6.4k 0.8× 8.3k 1.6× 4.6k 0.9× 5.3k 1.2× 2.0k 0.8× 341 16.9k
Mel Β. Feany United States 54 5.4k 0.7× 5.2k 1.0× 4.8k 1.0× 4.8k 1.1× 2.0k 0.8× 106 13.4k
Leonidas Stefanis Greece 55 4.8k 0.6× 7.4k 1.5× 3.6k 0.7× 3.6k 0.8× 2.1k 0.9× 277 13.4k
Nobuyuki Nukina Japan 62 9.1k 1.1× 3.4k 0.7× 4.9k 1.0× 4.3k 1.0× 2.3k 1.0× 206 14.6k
Pamela J. McLean United States 55 4.3k 0.5× 6.4k 1.3× 3.7k 0.8× 4.3k 1.0× 2.2k 0.9× 112 12.0k
Veerle Baekelandt Belgium 58 5.3k 0.6× 4.7k 0.9× 3.4k 0.7× 2.7k 0.6× 1.1k 0.5× 218 11.7k
Richard Wade‐Martins United Kingdom 55 4.4k 0.5× 4.6k 0.9× 3.1k 0.6× 2.5k 0.6× 908 0.4× 161 10.5k
Mark Cookson United States 81 11.6k 1.4× 13.5k 2.7× 6.4k 1.3× 6.2k 1.4× 3.4k 1.4× 258 24.9k
Philipp J. Kahle Germany 56 5.0k 0.6× 6.9k 1.4× 3.7k 0.8× 3.0k 0.7× 1.2k 0.5× 124 11.9k

Countries citing papers authored by Dimitri Krainc

Since Specialization
Citations

This map shows the geographic impact of Dimitri Krainc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Krainc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Krainc more than expected).

Fields of papers citing papers by Dimitri Krainc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri Krainc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Krainc. The network helps show where Dimitri Krainc may publish in the future.

Co-authorship network of co-authors of Dimitri Krainc

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitri Krainc. A scholar is included among the top collaborators of Dimitri Krainc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitri Krainc. Dimitri Krainc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krainc, Dimitri, et al.. (2024). Diverse Functions of Parkin in Midbrain Dopaminergic Neurons. Movement Disorders. 39(8). 1282–1288. 3 indexed citations
2.
Peng, Wesley, et al.. (2024). VPS13C regulates phospho-Rab10-mediated lysosomal function in human dopaminergic neurons. The Journal of Cell Biology. 223(5). 10 indexed citations
3.
Bustos, Bernabé I., Sara Bandrés‐Ciga, Thiago Peixoto Leal, et al.. (2024). Genome-wide epistasis analysis reveals significant epistatic signals associated with Parkinson’s disease risk. Brain. 148(6). 2060–2074. 1 indexed citations
4.
Peng, Wesley, et al.. (2023). Parkin regulates amino acid homeostasis at mitochondria-lysosome (M/L) contact sites in Parkinson’s disease. Science Advances. 9(29). eadh3347–eadh3347. 47 indexed citations
5.
Shum, Andrew, Sofia Zaichick, Gregory S. McElroy, et al.. (2023). Octopamine metabolically reprograms astrocytes to confer neuroprotection against α-synuclein. Proceedings of the National Academy of Sciences. 120(17). e2217396120–e2217396120. 10 indexed citations
6.
Song, Pingping, Wesley Peng, Véronique Sauvé, et al.. (2023). Parkinson’s disease-linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons. Neuron. 111(23). 3775–3788.e7. 29 indexed citations
7.
Krainc, Dimitri, et al.. (2022). Expanding the spectrum of KCNJ6 ‐related disorders: Milder phenotype with pathological startle responses. Clinical Genetics. 103(1). 103–108. 2 indexed citations
8.
Bustos, Bernabé I., Kimberley J. Billingsley, Cornelis Blauwendraat, et al.. (2022). Genome-wide contribution of common short-tandem repeats to Parkinson’s disease genetic risk. Brain. 146(1). 65–74. 20 indexed citations
9.
Ysselstein, Daniel, Tiffany Young, Maria Nguyen, et al.. (2021). Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity. Movement Disorders. 36(12). 2719–2730. 29 indexed citations
10.
Burbulla, Lena F., et al.. (2021). Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons. Scientific Reports. 11(1). 22257–22257. 7 indexed citations
11.
Kim, Soojin, Yvette C. Wong, Fanding Gao, & Dimitri Krainc. (2021). Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease. Nature Communications. 12(1). 1807–1807. 128 indexed citations
12.
Peng, Wesley, Yvette C. Wong, & Dimitri Krainc. (2020). Mitochondria-lysosome contacts regulate mitochondrial Ca2+dynamics via lysosomal TRPML1. Proceedings of the National Academy of Sciences. 117(32). 19266–19275. 221 indexed citations breakdown →
13.
Bustos, Bernabé I., Sara Bandrés‐Ciga, J. Raphael Gibbs, et al.. (2020). Replication assessment of NUS1 variants in Parkinson's disease. Neurobiology of Aging. 101. 300.e1–300.e3. 7 indexed citations
14.
Burbulla, Lena F., Sohee Jeon, Jianbin Zheng, et al.. (2019). A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s disease. Science Translational Medicine. 11(514). 84 indexed citations
15.
Graves, Steven M., Zhong Xie, Kristen A. Stout, et al.. (2019). Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain. Nature Neuroscience. 23(1). 15–20. 121 indexed citations
16.
Čaušević, Mirsada, Martina Pigoni, Alessio Colombo, et al.. (2018). BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains. PLoS ONE. 13(7). e0200344–e0200344. 13 indexed citations
17.
Al‐Ramahi, Ismael, Sai Srinivas Panapakkam Giridharan, Yu‐Chi Chen, et al.. (2017). Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein. eLife. 6. 51 indexed citations
18.
Burbulla, Lena F., Pingping Song, Joseph R. Mazzulli, et al.. (2017). Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease. Science. 357(6357). 1255–1261. 625 indexed citations breakdown →
19.
Lim, Maria, Mary Selak, Z. Xiang, et al.. (2012). Reduced Activity of AMP-Activated Protein Kinase Protects against Genetic Models of Motor Neuron Disease. Journal of Neuroscience. 32(3). 1123–1141. 84 indexed citations
20.
McDermott, John C., M. Cristina Cardoso, Yie‐Teh Yu, et al.. (1993). hMEF2C Gene Encodes Skeletal Muscle- and Brain-Specific Transcription Factors. Molecular and Cellular Biology. 13(4). 2564–2577. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026